
Edge Therapeutics
A biotechnology company, transforms FDA-approved drugs into therapies that address unmet acute neurological conditions.
Employees
Enterprise value
$224—336m
Authorizing premium user...
A biotechnology company, transforms FDA-approved drugs into therapies that address unmet acute neurological conditions.